Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 274 No 7355 p784
25 June 2005

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Little antibiotic benefit in LRTIs

Cough lasts same time with antibiotics

Cough lasts same time with antibiotics

Antibiotics offer little benefit over no treatment in relieving the symptoms of acute lower respiratory tract infections, according to researchers (JAMA 2005;293:3029).

Paul Little, primary care medical group, University of Southampton, and colleagues studied 807 adults and children to estimate the effectiveness of three prescribing strategies and an information leaflet.

Patients received either amoxicillin 250mg three times a day (or erythromycin if allergic to penicillin) for 10 days, a prescription for delayed antibiotics (patients were advised to collect it if their symptoms had not resolved after 14 days) or no offer of antibiotics. In each group half the patients received an information leaflet about the natural history of the illness and the proposed prescribing strategy. Resolution of symptoms was assessed via a patient diary.

The researchers say that compared with no treatment the other strategies offered little benefit in terms of cough duration and severity; this was still true for patients over 60 years old and those with green sputum production. However, re-attendance rates within one month of consultation were lower in the
antibiotic treatment groups compared with the third group (P=0.04).

“The use of delayed antibiotics or no antibiotics was acceptable, resulted in little difference in duration or severity of symptoms compared with immediate treatment with antibiotics and considerably reduced both antibiotic use and belief in antibiotics,” say the researchers.

Giving an information leaflet had no effect on symptom duration or severity but increased re-attendance rates (P=0.02).

Back to Top


©The Pharmaceutical Journal